See also
ˇ Show More
The cash flow statement provides information about a company's cash receipts and cash payments during an accounting period, showing how these cash flaws link the ending cash balance to the beginning balance shown on the company's statement of financial position.
The cash flow statement consists of three parts: cash flows provided by (used in) operating activities, cash flows provided by (used in) investing activities, and cash flows provided by (used in) financing activities.
You have visited 10 password protected pages for free. Others contain data covered by 
.
Sign Up Now to get full access to whole website and cut out all advertisements.
Novartis AG, Consolidated Statement of Cash Flows
USD $ in millions
| 12 months ended | Dec 31, 2011 | Dec 31, 2010 | Dec 31, 2009 | Dec 31, 2008 | Dec 31, 2007 | |
|---|---|---|---|---|---|---|
 |
Net income from continuing operations | |
|
|
|
|
|
Taxes | |
|
|
|
|
|
Depreciation, amortization and impairments on property, plant & equipment | |
|
|
|
|
|
Amortization and impairments on intangible assets | |
|
|
|
|
|
Amortization and impairments on financial assets | |
|
|
|
|
|
Income from associated companies | |
|
|
|
|
|
Gains on disposal of property, plant & equipment, intangible, financial and other non-current assets, net | |
|
|
|
|
|
Equity-settled compensation expense | |
|
|
|
|
|
Change in provisions and other non-current liabilities | |
|
|
|
|
|
Net financial income | |
|
|
|
|
|
Reversal of non-cash items | |
|
|
|
|
|
Dividends from associated companies | |
|
|
|
|
|
Dividends received from marketable securities | |
|
|
|
|
|
Interest received | |
|
|
|
|
|
Interest paid | |
|
|
|
|
|
Other financial receipts | |
|
|
|
|
|
Other financial payments | |
|
|
|
|
|
Taxes paid | |
|
|
|
|
|
Cash flow before working capital and provision changes of continuing operations | |
|
|
|
|
|
Restructuring payments and other cash payments from provisions | |
|
|
|
|
|
Change in inventories | |
|
|
|
|
|
Change in trade receivables | |
|
|
|
|
|
Change in trade payables | |
|
|
|
|
|
Change in other net current assets and other operating cash flow items | |
|
|
|
|
|
Change in net current assets and other operating cash flow items | |
|
|
|
|
|
Cash flow from operating activities of continuing operations | |
|
|
|
|
|
Cash flow for/from operating activities of discontinued operations | |
|
|
|
|
|
Cash flow from operating activities | |
|
|
|
|
|
Purchase of property, plant & equipment | |
|
|
|
|
|
Proceeds from sales of property, plant & equipment | |
|
|
|
|
|
Purchase of intangible assets | |
|
|
|
|
|
Proceeds from sales of intangible assets | |
|
|
|
|
|
Purchase of financial assets | |
|
|
|
|
|
Proceeds from sales of financial assets | |
|
|
|
|
|
Purchase of non-current non-financial assets | |
|
|
|
|
|
Proceeds from sales of non-current non-financial assets | |
|
|
|
|
|
Acquisition of interest in associated company | |
|
|
|
|
|
Acquisitions and divestments of businesses | |
|
|
|
|
|
Acquisition of non-controlling interests | |
|
|
|
|
|
Purchase of marketable securities | |
|
|
|
|
|
Proceeds from sales of marketable securities | |
|
|
|
|
|
Cash flow used for investing activities of continuing operations | |
|
|
|
|
|
Cash flow from/for investing activities of discontinued operations | |
|
|
|
|
|
Cash flow used for investing activities | |
|
|
|
|
|
Acquisition of treasury shares | |
|
|
|
|
|
Disposal of treasury shares | |
|
|
|
|
|
Increase in non-current financial debts | |
|
|
|
|
|
Repayment of non-current financial debts | |
|
|
|
|
|
Change in current financial debts | |
|
|
|
|
|
Proceeds from issuance of share capital to third parties | |
|
|
|
|
|
Withholding tax recoverable and related cash flows, net | |
|
|
|
|
|
Acquisition of Alcon non-controlling interests | |
|
|
|
|
|
Dividends paid to non-controlling interests and other financing cash flows | |
|
|
|
|
|
Dividends paid to shareholders of Novartis AG | |
|
|
|
|
|
Cash flow from/used for financing activities of continuing operations | |
|
|
|
|
|
Cash flow from/for financing activities of discontinued operations | |
|
|
|
|
|
Cash flow from/used for financing activities | |
|
|
|
|
|
Net effect of currency translation on cash and cash equivalents | |
|
|
|
|
|
Net change in cash and cash equivalents at year-end of discontinued operations | |
|
|
|
|
|
Net change in cash and cash equivalents of continuing operations | |
|
|
|
|
|
Cash and cash equivalents at January 1 | |
|
|
|
|
|
Cash and cash equivalents at December 31 | |
|
|
|
|
| Item | Description | The company |
|---|---|---|
| Cash flow from operating activities | The net cash from (used in) all of the entity's operating activities, including those of discontinued operations, of the reporting entity. Operating activities generally involve producing and delivering goods and providing services. Operating activity cash flows include transactions, adjustments, and changes in value that are not defined as investing or financing activities. | Novartis AG's cash flow from operating activities increased from 2009 to 2010 and from 2010 to 2011. |
May 23, 2012